Home > Healthcare > Medical Devices > Implantable Devices > Absorbable Nasal Implant Devices Market

Absorbable Nasal Implant Devices Market Trends

  • Report ID: GMI5679
  • Published Date: May 2023
  • Report Format: PDF

Absorbable Nasal Implant Devices Market Trends

The increasing prevalence of nasal congestion and the surging number of nasal reconstruction surgeries is escalating the demand for absorbable nasal implants. Nasal congestion refers to obstruction and reduced airflow in the nasal cavity in clinical practice. Multiple conditions are related with congestion that comprises nasal polyposis, obstructive sleep apnea, and anatomic variation. These conditions significantly impair quality of life, congestion leads to reduced daytime productivity and lower night-time sleep time & quality.

As per the National Centers for Biotechnology Information (NCBI) article, in 2019, rhinosinusitis impacts tens of millions of Americans, further leading to nearly USD 6 billion in overall health care expenditures. Statistics indicate that the allergic rhinitis prevalence varies significantly, from 10% to as high as 40%. Overall, the approximate prevalence rate is around 10% to 20% of the global population, with the prevalence of allergic rhinitis increasing since the last 2 to 3 decades. Thus, the high prevalence of these conditions is promoting share.

In addition, considering the high prevalence coupled substantial economic & social burden of this condition, there continues to be a notable unmet clinical need for effective therapeutic alternatives for these conditions. This development further offers a market penetration and business expansion opportunity for the key players. As a result, the growing number for surgical procedures, the rising prevalence of nasal congestion along with associated conditions, and under-penetrated market opportunity is supporting business growth.  

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

The market size of absorbable nasal implant devices reached USD 581 million in 2022 and will exceed USD 1,160 million by 2032.

The polymer-based absorbable nasal implants segment is slated to attain 7.2% CAGR from 2023 to 2032 due to benefits such as reduced inflammation and lower risk of infection.

The U.S. market for absorbable nasal implant devices will surpass USD 415 million by 2032 owing to the rising number of nasal reconstruction surgeries, and growing awareness regarding nasal implants.

Smith and Nephew plc, Intersect ENT, Inc., Spirox, Inc. (Entellus Medical), Stryker Corporation, and Johnson & Johnson are some of the key manufacturers of absorbable nasal implant devices.

Absorbable Nasal Implant Devices Market Scope

Buy Now

Premium Report Details

  • Base Year: 2022
  • Companies covered: 7
  • Tables & Figures: 373
  • Countries covered: 30
  • Pages: 200
 Download Free Sample